A progression-associated T-cell signature, HNSC-TstcSig, is developed that predicts immunotherapy response and reflects immune-active tumor states in HNSCC and suggests that ICOS is associated with a tumor-reactive CD8 T-cell state characterized by cytotoxic activity and immune checkpoint-related features.
A comprehensive overview of the functional regulation of MDK in cancer is provided, summarizing its molecular signaling pathways, contributions to tumor microenvironment remodeling, and involvement in therapeutic resistance.
D. Wusiman, Xue-Zeng Yang, Xiao-Tong Yan et al.· Cancer Genetics· 0 citations
This review comprehensively examines the current evidence for diverse biomarkers predictive of HNSCC response to anti‐PD‐1/PD‐L1 therapy, including but not limited to PD‐L1 expression, tumor mutational burden, features of the tumor microenvironment (TME), and circulating biomarkers.
Xiao‐Tong Yan, Zhaohong An, C. An· World Journal of Otorhinolar...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.